ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,013 filers reported holding ASTRAZENECA PLC in Q2 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,966,272 | +16.2% | 38,034 | +0.9% | 1.00% | +16.4% |
| Q1 2024 | $2,553,701 | +1.7% | 37,693 | +1.1% | 0.86% | -12.6% |
| Q4 2023 | $2,510,000 | +46.0% | 37,268 | +46.8% | 0.98% | +27.1% |
| Q3 2023 | $1,719,479 | -5.4% | 25,391 | 0.0% | 0.77% | +31.9% |
| Q2 2023 | $1,817,234 | +13.5% | 25,391 | +10.1% | 0.59% | +132.9% |
| Q1 2023 | $1,600,803 | +193.5% | 23,063 | +186.7% | 0.25% | +44.8% |
| Q4 2022 | $545,383 | +23.7% | 8,044 | 0.0% | 0.17% | +16.8% |
| Q3 2022 | $441,000 | -16.9% | 8,044 | 0.0% | 0.15% | -8.0% |
| Q2 2022 | $531,000 | -32.9% | 8,044 | -32.6% | 0.16% | -34.4% |
| Q1 2022 | $791,000 | +2.5% | 11,927 | -10.0% | 0.25% | +2.5% |
| Q4 2021 | $772,000 | -2.9% | 13,245 | 0.0% | 0.24% | -5.9% |
| Q3 2021 | $795,000 | +0.6% | 13,245 | +0.5% | 0.26% | +11.8% |
| Q2 2021 | $790,000 | +21.9% | 13,183 | +1.1% | 0.23% | +9.0% |
| Q1 2021 | $648,000 | +1.6% | 13,035 | +2.2% | 0.21% | -12.5% |
| Q4 2020 | $638,000 | – | 12,759 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |